long intergenic non-protein coding RNA 2473Genealiases: []
Q-omics provides the consensus-scored LINC02473 profile across patient tissues and cancer cell-line models. LINC02473 expression is associated with patient survival in 25 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, LINC02473 is differentially expressed in 9, with the highest sampling consensus in KIRC. Additionally, LINC02473 RNA expression shows 12,040 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight KIRP, KIRC, and GBM as cancer lineages where LINC02473 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02473 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02473 survival associations across molecular data types. LINC02473 RNA expression shows survival associations in the most cancer types (25). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02473 RNA expression–survival associations across cancer types. High LINC02473 expression shows unfavorable associations in KIRP, UVM, LGG, LIHC and BRCA, but favorable associations in ESCA. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for LINC02473 RNA expression.
This table summarizes LINC02473 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02473. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02473 shows lower tumor expression in KICH and higher tumor expression in KIRC, LUAD, UCEC, COAD and LUSC. The KIRC box plot shows higher LINC02473 RNA expression in tumor versus normal tissue (log2 FC = +0.308, t-test p < 0.001).
This table shows molecular features associated with LINC02473 in patient tissues and cancer cell lines. In patient samples, LINC02473 shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
